Variable | n | Mean | Min | Median | Max |
---|
PE
|
B
aut
/H
aut
| 40 | 4.33 | .6 | 3.00 | 25.00 |
Base case
|
B
1
/H
1
| 40 | 6.28 | 0.75 | 3.18 | 49.50 |
Low risk
|
B
1
/H
1
| 39 | 12.46 | 0.66 | 5.26 | 100.00 |
High risk
|
B
1
/H
1
| 41 | 1.76 | 0.05 | 0.98 | 18.80 |
AML
|
B
aut
/H
aut
| 41 | 2.29 | 0.43 | 2.00 | 10.00 |
Base case
|
B
1
/H
1
| 41 | 1.55 | 0.00 | 1.00 | 7.07 |
Low risk
|
B
1
/H
1
| 39 | 4.39 | 0.00 | 1.94 | 22.50 |
High risk
|
B
1
/H
1
| 40 | 0.70 | 0.00 | 0.50 | 3.00 |
- Abbreviations: B
aut
/H
aut
assessment of benefit/harms ratio based on automatic, quick response, B
1
/H
1
-type 1 response driven by regret, PE pulmonary embolism, AML acute myeloid leukemia, low “risk” low threshold, high “risk” high threshold clinical decisions. [*Note that type 2 responses that relied on single values, fixed B2/H2 ratios precluding direct statistical comparisons with Baut/Haut. However, the values of B2/H2 differed considerably from Baut/Haut (from 1 to 10 in PE case, and 2 to 0.33 in AML case) consistent with a notion that the Baut/Haut estimates did not solely drive the decision-making (see Discussion)].